Forgot your password?
New User?
Remember me
banner banner

You are here:Home » Biochemicals » Biochem-Drugs/Analogues » Gefitinib, Free Base (Iressa)

Gefitinib, Free Base (Iressa)


  For pricing information, USA customers sign in.
  Outside USA? Please contact your distributor for pricing.


EGFR tyrosine kinase inhibitor that binds to the ATP-binding site of the enzyme. The functions of the EGFR tyrosine kinase in activating the Ras signal transduction cascade and malignant cell growth are thus inhibited. It has been shown that a mutation in the EGFR tyrosine kinase domain is responsible for activating anti-apoptotic pathways in gefitinib-sensitive non-small cell lung cancers. These mutations tend to increase sensitivity to tyrosine kinase inhibitors including gefitinib and erlotinib. The adenocarcinoma subset of non-small cell lung cancer histologies often have these mutations, which are commonly found in Asians, women, and non-smokers.
Catalog #G2023-95A
SolubilitySoluble in DMSO, up to about 100mg/ml; very poorly soluble in water or ethanol.
Melting Point188-193°C
Elemental AnalysisCalculated:
C - 59.13%
H - 5.41%
Cl - 7.93%
F - 4.25%
N - 12.54%
Storage and StabilityMay be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
CAS Number184475-35-2
Molecular FormulaC22H24ClFN4O3
Molecular Weight446.90
FormSupplied as a white to off-white powder.
Important NoteThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

External Links